Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature
| Autor: | Fatima K. Alshahrani, Mervat Mahrous, Medina A. Ahmed, Ghadah Almutiri, Fatehi Elzein, Eid Alsufyani, Ahmed Ibrahim, Meshal Altowairqi, Esam Murshid, Nouf Alnawshan, Mohammed Alsaeed, Turki Aldhehyan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Male Pediatrics medicine.medical_specialty Coronavirus disease 2019 (COVID-19) 030106 microbiology Disease Asymptomatic Article Episode lcsh:Infectious and parasitic diseases 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Tocilizumab Recurrence Medicine Humans SARS-cov-2 lcsh:RC109-216 030212 general & internal medicine Dexamethasone business.industry lcsh:Public aspects of medicine Public Health Environmental and Occupational Health COVID-19 lcsh:RA1-1270 General Medicine Middle Aged medicine.disease Pulmonary embolism Infectious Diseases chemistry Reinfection Etiology Female Presentation (obstetrics) medicine.symptom business medicine.drug |
| Zdroj: | Journal of Infection and Public Health, Vol 14, Iss 4, Pp 474-477 (2021) Journal of Infection and Public Health |
| ISSN: | 1876-0341 |
| Popis: | Background Severe acute respiratory syndrome coronavirus 2 (SARS-cov-2), first described in December 2019, has now infected more than 28 million cases with almost one million deaths. Reinfection is not definitely established however disease recurrence is increasingly reported. Cases presentation Four patients presented with a second episode of coronavirus disease 2019 (COVID-19) occurring 27–85 following their first illness. The initial episode was mild or asymptomatic while the second attack was severe requiring hospital admission. All four patients had a SARS-CoV-2 PCR test positive in the second episode. The chest-X-ray and/or computerized tomography (CT) scan showed bilateral alveolar shadows. Furthermore, the inflammatory markers were raised in the four patients. Three patients recovered following treatment with favipravir in addition tocilizumab and/or dexamethasone. Conclusion Covid19 reinfection Recurrent COVID-19 is increasingly reported. However; other etiologies including superadded infection or pulmonary embolism should be ruled out, particularly if recurrence occurs less than 3 weeks. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|